Across TCGA pan-cancer cohorts, MIR4274 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated MIR4274 data layer.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MIR4274 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4274 expression acts as an unfavorable survival marker.
BLCA, THYM, and STAD are the cancer types where MIR4274 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.